The study design followed a country-specific adaption of the EPIC Common Approach, which was developed to harmonize methods for costing and financing analyses under the umbrella of the Bill & Melinda Gates Foundation financed multi-country studies. Along with the findings from the other five country studies in Africa and Europe selected for EPIC, the results described in this report aim to contribute to the global evidence base on immunization costs and improve planning and budgeting processes at the local level and more broadly.
This study shows that even with the addition of new, more expensive vaccines to the routine schedule, system costs account for the majority of the resources used in the delivery of Honduras’ national immunization program. Additionally, the financial flows mapping demonstrates that the government currently finances the majority of the program needs. Still, there are important operational activities that may face financing gaps with the impending graduation from Gavi vaccine subsidies and health systems grants. In the near and long term, the government’s primary strategy to ensure sustainability and to maintain the great progress the program has made in reducing vaccine-preventable diseases is tied to securing 100% of immunization financing from domestic sources. The study contributes key information to enable better mobilization and management of resources for immunization. Integrating the type of costing and financing data collected in this study with other program performance measures will enable more accurate resource planning and identification of opportunities to improve efficiency.
